Menu ×


Automated Cell Culture System Market Analysis by Product Type (Consumables, Bioreactors, and Equipment); by Line Culture (Finite Cell and Infinite Cell); by Application (Drug Development, Stem Cell & Cancer Research, and Others); by Mode of Delivery (Topical Application, Aerial Diffusion, and Direct Inhalation); and by End-User (Academic Institutes, Biotech Company, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • Hitachi Power Solutions Co., Ltd. to launch FineSAT7, a scanning acoustic tomograph with higher image quality. this scanning acoustic tomograph is used to detect particular defects in the body with help of transmissive and reflective properties of ultrasonic waves. 
  • Becton, Dickinson and Company to start the enrollment for the first-in-human trial for sirolimus drug-coated balloons (DCB). The company is conducting these trials to improve the treatment option for peripheral arterial diseases.

Global Automated Cell Culture System Market Size, Forecast, and Trend Highlights Over 2023 - 2033

Base Year


Forecast Period

2023 – 2033



Base Year Market Size (2022)

~USD 6500.0 Million

Forecast Year Market Size (2033)

~USD 12432.5 Million

The global automated cell culture system market is estimated to garner robust revenue of ~USD 12432.5 million by the end of 2033 by growing at a CAGR of ~12.4% over the forecast period, i.e., 2023 – 2033. Further, the market generated remarkable revenue of ~USD 6500.0 million in the year 2022. The growth of the market can primarily be attributed to the increasing stem cell research & development owing to the higher prevalence of related diseases. For instance, in 2019, more than 8 million people were found to be suffering from Parkinson’s disease.

Automated-Cell-Culture-System-Market-Demand-AnalysisGet more information on this report: Request Sample PDF

A cell culture system is a process that consists particular instrument to conduct steps to grow and maintain cell culture. In a cell culture system, an environment is constituted to with controlled conditions, separated from the natural environment. Global automated cell culture market trends such as, escalating research and development activities and spiking prevalence of cancer are expected to influence the growth of the market over the forecast period. According to World Health Organization, cancer is designated as the leading cause of death, which caused about 10 million deaths in 2020, it is also stated by the similar source that in every 6 deaths, 1 is caused by cancer.

Global Automated Cell Culture System Market: Growth Drivers and Challenges

Growth Drivers

  • Significant Demand in the Treatment of Skin Problems

In 2022, over 6 million Americans were found to be living with psoriasis while about 200 million were across the globe.

The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.

  • Rising Cases of Non-Communicable Diseases

Data published by the World Health Organization showed that nearly 41 million individuals die due to non-communicable diseases every year.

  • Higher Prevalence of Infectious Diseases  

The annual rate of death caused by infectious diseases is estimated to be more than 15 million a year.

  • Growing Healthcare Expenditure Across the Globe

As per the statistics provided by the World Bank, global health expenditure was estimated to reach USD 1,121.9 per capita.

  • Increasing Number of Clinical Trials  

As of 2021, the number of clinical trials is estimated to be nearly 0.4 million in about 200 countries.


  • Lack of Skilled Medical Professionals
  • Lack of Required Technology to Develop the Cell Culture System
  • Requirement for Higher Initial Investment

The global automated cell culture system market is segmented and analyzed for demand and supply by end-user into academic institutes, biotech company, and research organization, out of which, the biotech company segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising activities of research and development across the globe. For instance, the biotech industry was valued at approximately USD 450 billion in 2020.

On the other, on the basis of mode of delivery, automated cell culture system market is segmented into topical application, aerial diffusion, and direct inhalation. Out of all these, the topical application garnered the highest market share i.e. 41.03% in 2022. The rising technological advancements along with the huge investments made in the healthcare sector is expected to bring lucrative opportunities for the segment growth.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Automated Cell Culture System Market Regional Synopsis

Regionally, the global automated cell culture system market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region holds the largest market share with 42.16% in 2022. The growth of the market is attributed to rising investment in research and development in the region. The National Cancer Institute (NIC) published statistics showing that the NCI budget to make funding for research for cancer reached USD 6440.4 million in 2020. Additionally, the higher prevalence of chronic diseases and the presence of major key players in the region is further expected to propel the growth of the market over the forecast period. Furthermore, the Europe region is also estimated to provide a lucrative opportunity for the market to grow exponentially.


The global automated cell culture system market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global automated cell culture system market includes the following segments:


By Product Type

  • Consumables
  • Bioreactors
  • Equipment


By Line Culture

  • Finite Cell
  • Infinite Cell


By Application

  • Drug Development
  • Stem Cell & Cancer Research
  • Regenerative Medicine

By Mode of Delivery

  • Topical Application – 41.03%
  • Aerial Diffusion – 23.5%
  • Direct Inhalation – 35.5%


By End-User

  • Academic Institutes
  • Biotech Company
  • Research Organization

Top Featured Companies Dominating the Global Automated Cell Culture System Market

  • Hitachi Power Solutions Co, Ltd.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Lonza Group Ltd.
  • Thermo Fisher Scientific Company
  • Cell Culture Company, LLC
  • Sartorius AG
  • Becton, Dickinson and Company
  • Hamilton Company
  • Merck Group
  • F. Hoffmann-La Roche AG
  • Novartis AG



Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved